SERPINA5

Serpin Family A Member 5 (Protein C Inhibitor)

Gene Information Card

Symbol SERPINA5
Full Name Serpin Family A Member 5
Gene Type protein-coding
Chromosomal Location 14q32.13
NCBI Gene ID 5104 ncbi.nlm.nih.gov/gene/5104
Ensembl ID ENSG00000100884
UniProt ID P05154
OMIM ID 601841
HGNC ID 8983
Aliases PCI, PROCI, PLANH3, PAI-3

Description

SERPINA5 encodes protein C inhibitor (PCI), a serine protease inhibitor belonging to the serpin superfamily. PCI inhibits activated protein C, thrombin, plasminogen activators, and other proteases, playing a key role in regulating coagulation, fibrinolysis, and inflammation. It is expressed in many tissues, including liver, kidney, and reproductive organs, and has been implicated in thrombosis, infertility, and cancer progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Thrombophilia Loss of PCI function reduces inhibition of activated protein C, promoting hypercoagulability. ClinVar, OMIM
Male infertility PCI deficiency in seminal plasma impairs sperm capacitation and motility. UniProt, PubMed
Prostate cancer Altered SERPINA5 expression affects tumor invasion and metastasis via protease regulation. COSMIC, PubMed
Endometrial cancer Reduced PCI expression correlates with aggressive tumor phenotype. COSMIC, PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 43.2 High
Kidney 28.5 Medium
Prostate 22.1 Medium
Testis 18.7 Medium
Lung 12.3 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 35.6 Hepatocellular carcinoma cell line
HEK 293 15.2 Embryonic kidney cells
LNCaP 20.4 Prostate cancer cell line
MCF7 8.9 Breast cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1073G>A (p.Arg358His) Missense Rare Reduced inhibitory activity toward activated protein C
c.1196G>A (p.Arg399Gln) Missense Rare Altered heparin binding and stability
c.1A>G (p.Met1Val) Start loss Very rare Loss of protein expression
Mutation functional classification

Loss of Function (LOF)

Missense variants (e.g., p.Arg358His) reduce protease inhibition, leading to thrombotic risk.

Gain of Function (GOF)

Not well documented; no clear gain-of-function variants reported.

Dominant Negative (DN)

No evidence for dominant-negative effects; SERPINA5 acts as a monomer.

Gene Ontology (GO)

• serine-type endopeptidase inhibitor activity • heparin binding
• extracellular space • blood coagulation
• negative regulation of fibrinolysis • negative regulation of angiogenesis

Pathways

Intrinsic pathway of fibrin clot formation (Reactome: R-HSA-140837)
Common pathway of fibrin clot formation (Reactome: R-HSA-140875)
Protein C anticoagulant pathway (KEGG: hsa04610)

Protein Summary

Protein C inhibitor (PCI) is a 57 kDa glycoprotein secreted primarily by the liver and found in plasma, seminal fluid, and urine. It inhibits activated protein C, thrombin, factor Xa, and urokinase-type plasminogen activator. PCI contains a reactive center loop (RCL) that traps target proteases via a suicide substrate mechanism. Its activity is modulated by heparin and other glycosaminoglycans. Dysregulation of PCI contributes to thrombosis, infertility, and tumor progression.

Related Products

Product name Cat.No. Species Gene ID
SERPINA5 Knockout HEK293 Cell Line EDJ-KQ5413 Human 5104 Details Get a Quote
SERPINA5 Knockout HCT 116 Cell Line EDJ-KQ27334 Human 5104 Details Get a Quote
SERPINA5 Knockout HeLa Cell Line EDJ-KQ54091 Human 5104 Details Get a Quote
SERPINA5 Knockout A-549 Cell Line EDJ-KQ62579 Human 5104 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: